Abstract:BACKGROUND & AIMS:A common variant in the solute carrier family 39 member 6 gene (SLC39A6) has been associated with survival times of patients with esophageal squamous cell carcinoma (ESCC). We investigated the function of SLC39A6 and ways in which this variant affects tumor progression by studying ESCC samples and cell lines.METHODS:SLC39A6 was expressed or knocked down by expression of short hairpin RNAs in ESCC cells (KYSE30 and KYSE450) and HeLa cells using lentiviral vectors; we analyzed effects on proliferation, colony formation, migration, and invasion in vitro. Cells were grown as xenograft tumors in nude mice and tumor volume and metastases were quantified; tumors were collected and analyzed histologically. Cells were also analyzed for levels of intracellular zinc and messenger RNA (mRNA) expression patterns. We obtained ESCC and adjacent normal esophageal tissues from 94 patients who underwent esophagectomy in China from 2010 through 2014. Survival times of patients were measured from the date of diagnosis to the date of last follow-up or death. We sequenced mRNAs and compared levels between tumor and non-tumor tissues using the Wilcox rank-sum test. Total proteins in cell lines or tissue samples were measured by immunoblotting. We searched publicly available databases for variants of SLC39A6 in human tumor and non-tumor tissues.RESULTS:Knockdown of SLC39A6 reduced proliferation of ESCC cells in culture and metastasis of xenograft tumors in mice. Cells that overexpressed SLC39A6 had significant increases in intracellular levels of zinc and were more invasive in assays, activating phosphatidylinositol 3-kinase signaling to AKT serine/threonine kinase 1 and mitogen-activated protein kinase 1. Cells that overexpressed SLC39A6 had increased expression of mRNAs and proteins associated with metastasis, such as matrix metalloproteinase (MMP) 1, MMP3, MYC, and snail family transcriptional repressor 2 (SNAI2 or SLUG). Levels of MMP1, MMP3, MYC, and SLUG mRNAs correlated with levels of SLC39A6 mRNA in ESCC samples from patients. ESCC tissues had increased levels of SLC39A6 mRNA compared with non-tumor tissues; the increase correlated with tumor metastasis to lymph node and reduced patient survival time.CONCLUSIONS:In an analysis of ESCC samples and cell lines, we associated increased expression of SLC39A6 with tumor invasiveness, intracellular level of zinc, and patient survival time. ESCC cell lines that overexpress SLC39A6 up-regulate expression MMP1, MMP3, MYC, and SLUG and form metastatic xenograft tumors in mice. Up-regulation of SLC39A6 might be used to determine prognoses of patients with ESCC or as a therapeutic target.

Increased WNT6 Expression in Tumor Cells Predicts Unfavorable Survival in Esophageal Squamous Cell Carcinoma Patients.

[Expression of Six1 and Six4 in esophageal squamous cell carcinoma and their correlation with clinical prognosis].

TRPV6 Plays a New Role in Predicting Survival of Patients with Esophageal Squamous Cell Carcinoma.

Abnormal P16 Expression and Prognostic Significance in Esophageal Squamous Cell Carcinoma.

76 WHOLE-EXOME SEQUENCING EXPLORES DIFFERENTIAL GENES EXPRESSION OF METASTASIS IN ESOPHAGEAL SQUAMOUS CELL CARCINOMA: A PROPENSITY-SCORE MATCHING STUDY

High Expression of Transient Potential Receptor C6 Correlated with Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma

Expression of Integrin β6 and HAX-1 Correlates with Aggressive Features and Poor Prognosis in Esophageal Squamous Cell Carcinoma.

Increased HOXC6 Expression Predicts Chemotherapy Sensitivity in Patients with Esophageal Squamous Cell Carcinoma.

14P High CMTM6 and PD-L1 co-expression predict metastasis and poor prognosis in oesophageal squamous cell carcinoma

Data from Characterization of Tumor-Suppressive Function of <i>sox6</i> in Human Esophageal Squamous Cell Carcinoma

Expression and Association of CD44v6 with Prognosis in T2-3N0M0 Esophageal Squamous Cell Carcinoma.

ADAMTS-6 is a predictor of poor prognosis in patients with esophageal squamous cell carcinoma.

SIX1 Overexpression Predicts Poor Prognosis and Induces Radioresistance Through AKT Signaling in Esophageal Squamous Cell Carcinoma.

Prognostic Significance of CDK6 Amplification in Esophageal Squamous Cell Carcinoma

Expression of proteins associated with epithelial-mesenchymal transition in esophageal squamous cell carcinoma.

The survival predictive significance of HOXC6 and HOXC8 in esophageal squamous cell carcinoma.

Long Noncoding RNA LSINCT5 is Upregulated and Promotes the Progression of Esophageal Squamous Cell Carcinoma

Association of Wnt1/β-catenin with the Clinical Pathology and Prognosis of Esophageal Squamous Cell Carcinoma

A Five-Gene Signature to Predict the Overall Survival Time of Patients with Esophageal Squamous Cell Carcinoma.

Clinicopathological Significance Of Sox4, Beta-Catenin, And Tcf4 Expression In Esophageal Squamous Cell Carcinoma

Solute Carrier Family 39 Member 6 Gene Promotes Aggressiveness of Esophageal Carcinoma Cells by Increasing Intracellular Levels of Zinc, Activating Phosphatidylinositol 3-Kinase Signaling, and Up-regulating Genes That Regulate Metastasis.